Trial intelligence / Profile preview

Oral lorazepam for headache related to spinal anesthesia in cesarean section

IRCT20210921052542N1Phase 3Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of lorazepam in post-dural puncture headache (PDPH) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Headache. Started Nov 2021; status: completed.

02

Drugs

lorazepam
03

Conditions

post-dural puncture headache (PDPH)

Beyond the preview

Go deeper on IRCT20210921052542N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210921052542N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call